October 23, 2026 Hammond Power Solutions Announces Third Quarter 2026 Financial Results Conference Call and Webcast Notification
October 23, 2026 Genmab Announces Rinatabart Sesutecan (Rina-S®) Demonstrates Statistically Significant Improvement in Progression-Free Survival and Overall Survival in Patients with Platinum-Resistant Ovarian Cancer